New thoughts on the diagnosis and treatment of patients with diabetes mellitus in relation to coronavirus disease

World J Diabetes. 2020 Nov 15;11(11):481-488. doi: 10.4239/wjd.v11.i11.481.

Abstract

The coronavirus disease 2019 (COVID-19) outbreak that occurred in late 2019 has posed a huge threat to the health of all humans, especially for individuals who already have diabetes mellitus (DM). DM is one of the most serious diseases that affect human health, with high morbidity and rates of complications. Medical scientists worldwide have been working to control blood sugar levels and the complications associated with sugar level alterations, with an aim to reduce the adverse consequences of acute and chronic complications caused by DM. Patients with DM face great challenges during the pandemic owing to not only changes in the allocation of medical resources but also their abnormal autoimmune status, which reduces their resistance to infections. This increases the difficulty in treatment and the risk of mortality. This review presents, from an epidemiological viewpoint, information on the susceptibility of patients with DM to COVID-19 and the related treatment plans and strategies used in this population.

Keywords: Antidiabetic medicine; Diabetes; Infection; Insulin; Novel coronavirus; Strategy.

Publication types

  • Review